Concepedia

Thomas Lind

TL

Statistics

Publications

24

Citations

1.5K

H-Index

18

Active since

1993

Affiliations

Uppsala University(Current)

Karolinska Institutet

Karolinska University Hospital

Uppsala University Hospital

Newcastle University

Thomas Lind is an author at Uppsala University specializing in bone metabolism, medicine, and molecular biology.

ORCID

Publications per year

1993–2019

24

Publications

24

The Putative Tumor Suppressors EXT1 and EXT2 Are Glycosyltransferases Required for the Biosynthesis of Heparan Sulfate

Thomas Lind, Frank Tufaro, Craig McCormick et al. · Journal of Biological Chemistry · 1998 · 425 citations · Full text

, , +15

The EXT1/EXT2 tumor suppressors: catalytic activities and role in heparan sulfate biosynthesis

Claire Senay, Thomas Lind, Kumi Muguruma et al. · EMBO Reports · 2000 · 168 citations · Full text

, , +13

Biosynthesis of heparin/heparan sulfate. Identification of a 70-kDa protein catalyzing both the D-glucuronosyl- and the N-acetyl-D-glucosaminyltransferase reactions.

Thomas Lind, Ulf Lindahl, Kerstin Lidholt · Journal of Biological Chemistry · 1993 · 87 citations · Full text

, , +15

Olfactory receptor 51E1 protein as a potential novel tissue biomarker for small intestine neuroendocrine carcinomas

Apostolos V. Tsolakis, Su‐Chen Li, Janet L. Cunningham et al. · European Journal of Endocrinology · 2012 · 79 citations · Full text

, , +15

Vitamin A Is a Negative Regulator of Osteoblast Mineralization

Thomas Lind, Anders Sundqvist, Lijuan Hu et al. · PLoS ONE · 2013 · 78 citations · Full text

, , +17

1–5 of 24